Maybe someone found out that Q2 brought great revenues, or that uplisting is around the corner, or that they have bought a fantastic new drug, or that one of the three drugs in the pipeline has been approved and is now ready for production, or institutional investors picking up...
So you see today's run could be caused by a lot of things
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.